Strata Skin Sciences Q2 2024 GAAP EPS $(0.03) Beats $(0.70) Estimate, Sales $8.40M Beat $7.42M Estimate
Portfolio Pulse from Benzinga Newsdesk
Strata Skin Sciences (NASDAQ:SSKN) reported Q2 2024 GAAP EPS of $(0.03), significantly beating the analyst estimate of $(0.70). The company also reported sales of $8.40 million, surpassing the $7.42 million estimate and showing a 1.82% increase from the same period last year.
August 14, 2024 | 8:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Strata Skin Sciences reported better-than-expected Q2 2024 results with a GAAP EPS of $(0.03) beating the $(0.70) estimate and sales of $8.40 million surpassing the $7.42 million estimate.
The significant beat on both EPS and sales estimates is likely to positively impact the stock price in the short term. Investors generally react favorably to companies that outperform expectations.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100